Recently, a large family-based study suggested that BRCA2 P/LPVs are associated with a statistically significant risk for stomach cancer, while associations of BRCA1 P/LPVs carriers with prostate cancer or cutaneous melanoma could not be confirmed [7]. The gene discussed is BRCA2; the disease is prostate cancer.